AESGP London office expected to be operational in early 1996; U.K. switches proposed.
This article was originally published in The Tan Sheet
Executive Summary
AESGP LONDON OFFICE WILL BE OPERATIONAL IN JANUARY 1996, the European Proprietary Medicine Manufacturers Association (AESGP) predicted. Currently, AESGP is scouting office space in the Canary Wharves district of London, the same district that houses the European Medicines Evaluation Agency (EMEA), which opened its office in January 1995. The main headquarters of AESGP will remain in Brussels; the London location would be the association's first satellite office.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning